Clinical Trial Update: Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating expanded/activated gamma delta T-cell infusion after hematopoietic stem cell transplantation with post-transplant cyclo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Chronic Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Gamma delta T-cell infusion (gamma-delta T-cell therapy)

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Acute Myeloid Leukemia, Chronic Myeloid Leukemia | Phase 1 | Status: RECRUITING